EuBiologics Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Other Revenue	-	-0	-	-	0
Revenue	96,035	69,366	55,467	39,385	28,490
Revenue Growth (YoY)	38.45%	25.06%	40.83%	38.24%	-
Cost of Revenue	-	35,405	31,918	24,167	21,590
Gross Profit	96,035	33,961	23,549	15,218	6,899
Selling, General & Admin	-	7,456	10,499	5,808	3,624
Research & Development	-	17,882	15,777	16,178	8,504
Other Operating Expenses	61,714	108.88	223.54	99.44	80.68
Operating Expenses	61,714	26,262	27,317	22,448	12,862
Operating Income	34,321	7,699	-3,769	-7,230	-5,962
Interest Expense	-	-488.05	-254.92	-588.81	-1,967
Interest & Investment Income	-	164.68	230.76	356.52	106.69
Earnings From Equity Investments	-	-512.58	-321.04	-124.61	-0.15
Currency Exchange Gain (Loss)	-	153.98	-56.99	40.34	-399.22
Other Non Operating Income (Expenses)	-10,537	-1,191	-657.25	-22,818	-55,229
EBT Excluding Unusual Items	23,784	5,826	-4,828	-30,364	-63,451
Gain (Loss) on Sale of Investments	-	-200.32	2,142	253.29	-180.6
Gain (Loss) on Sale of Assets	-	1,666	193.28	-0.88	-5.24
Asset Writedown	-	-21,906	-845.09	-708.04	-
Other Unusual Items	-	-	-	-	3,041
Pretax Income	23,784	-14,615	-3,338	-30,820	-60,595
Income Tax Expense	-1,082	745.04	99.24	-2,795	-460.79
Earnings From Continuing Operations	24,866	-15,360	-3,437	-28,025	-60,134
Minority Interest in Earnings	-	1,481	2,339	450.68	-
Net Income	24,866	-13,879	-1,099	-27,574	-60,134
Net Income to Common	24,866	-13,879	-1,099	-27,574	-60,134
Shares Outstanding (Basic)	-	36	36	35	28
Shares Outstanding (Diluted)	-	36	36	35	28
Shares Change (YoY)	-	0.13%	2.68%	26.53%	-
EPS (Basic)	-	-380.79	-30.19	-777.82	-2146.27
EPS (Diluted)	-	-381.00	-30.19	-778.00	-2146.27
Free Cash Flow	-	19,515	-2,626	-14,196	-6,371
Free Cash Flow Per Share	-	535.43	-72.15	-400.46	-227.38
Gross Margin	100.00%	48.96%	42.45%	38.64%	24.22%
Operating Margin	35.74%	11.10%	-6.79%	-18.36%	-20.93%
Profit Margin	25.89%	-20.01%	-1.98%	-70.01%	-211.07%
Free Cash Flow Margin	-	28.13%	-4.74%	-36.05%	-22.36%
EBITDA	-	16,867	4,113	-665.51	-13.19
EBITDA Margin	-	24.32%	7.42%	-1.69%	-0.05%
D&A For EBITDA	9,168	9,168	7,882	6,564	5,949
EBIT	34,321	7,699	-3,769	-7,230	-5,962
EBIT Margin	35.74%	11.10%	-6.79%	-18.36%	-20.93%
Advertising Expenses	-	186.94	237.98	47.13	35.88

Updated Mar 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.